Lipid nanoparticles have attracted significant interests in the last two decades, and have
achieved tremendous clinical success since the first clinical approval of Doxil in 1995. At the …

Nanoparticles (NPs) have attracted tremendous interest in drug delivery in the past decades.
Microfluidics offers a promising strategy for making NPs for drug delivery due to its capability …

Polymeric nanoparticles are highly important functional nanomaterials for a large range of
applications from therapeutics to energy. Advances in nanotechnology have enabled the …

Microfluidic technology is a relatively new field among the various conventional bulk
techniques employed for nanomaterial synthesis. Nanoparticles (NPs) produced using such …

Controllable and scalable synthesis of biomedical organic nanoparticles (NPs) with tailored
properties is critical for their clinical translation. However, the existing microfluidics-based …

Increasing drug loading remains a critical challenge in the development and translation of
nanomedicine. High drug‐loading nanoparticles have demonstrated unique advantages …

The encapsulation of peptides and proteins in nanosystems has been extensively
investigated for masking unfavorable biopharmaceutical properties, including short half-life …

Nanoparticles (NPs) have been widely investigated in the nanomedicine field. One of the
main challenges is to accurately predict the NP distribution and fate after administration …

Conventional batch syntheses of polymer-based nanoparticles show considerable
shortcomings in terms of scarce control over nanomaterials morphology and limited lot-to-lot …

Microreactor is an important functional device in a microfluidic system, which has a
significant impact on the overall performance of the microfluidic system. As an emerging …